Akagi H, Konishi S, Otsuka M, Yanagisawa M (1985) The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord. Br J Pharmacol 84:663–673
Beresford IJM, Birch PJ, Hagan RM, Ireland SJ (1991) Investigation into species variants in tachykinin NK1 receptors by use of the nonpeptide antagonist, CP-96,345. Br J Pharmacol 104:292–293
Constantine JW Lebel WS, Woody HA (1991) Inhibition of tachykinin-induced hypotension in dogs by CP-96,345, a selective blocker of NK-1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 344:471–477
Conover WJ (1980) Practical Nonparametric Statistics. 2nd edn. Wiley, New York, pp 295–299
Cridland RA, Henry JL (1988) Facilitation of the tail-flick reflex by noxious cutaneous stimulation in the rat: antagonism by a substance P analogue. Brain Res 462:15–21
Delay-Goyet P, Lundberg JM (1991) Cigarette smoke-induced airway oedema is blocked by the NK1 antagonist, CP-96,345. Eur J Pharmacol 203:157–158
Donnerer J, Lembeck F (1983) Capsaicin-induced reflex fall in rat blood pressure is mediated by afferent substance P-containing neurones via a reflex centre in the brain stem. Naunyn-Schmiedeberg's Arch Pharmacol 324:293–295
Donnerer J, Stark U, Tritthart HA, Lembeck F (1992) CP-96,345, a non-peptide antagonist of substance P: III. Cardiovascular effects unrelated to actions on substance P receptors. Naunyn-Schmiedeberg's Arch Pharmacol 346:328–332
Gitter BD, Waters DC, Bruns RF, Mason NR, Nixon JA, Howbert JJ (1991) Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol 197:237–238
Holzer P (1991) Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurones. Pharmacol Rev 43:143–201
Holzer-Petsche U, Schimek E, Amann R, Lembeck F (1985) In vivo and in vitro actions of mammalian tachykinins. Naunyn-Schmiedeberg's Arch Pharmacol 330:130–135
Konzett H, Rössler R (1940) Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 195:71–74
Legat FJ, Griesbacher T, Lembeck F (1992) CP-96,345, a non-peptide antagonist of substance P: 1. Effects on actions mediated by substance P and related tachykinins on the guinea-pig ileum and rabbit jejunum. Naunyn-Schmiedeberg's Arch Pharmacol 346:315–322
Lembeck F, Donnerer J (1983) Reflex fall in blood pressure mediated by capsaicin-sensitive afferent fibres of the rat splanchnic nerve. Naunyn-Schmiedeberg's Arch Pharmacol 322:286–289
Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A (1992) The non-peptide tachykinin antagonist CP-96,345 is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 105:527–530
Nussbaumer J-C, Yanagisawa M, Otsuka M (1989) Pharmacological properties of a C-fibre response evoked by saphenous nerve stimulation in an isolated spinal cord-nerve preparation of the newborn rat. Br J Pharmacol 98:373–382
Post C, Butterworth JF, Strichartz GR, Karlsson J-A, Persson CGA (1985) Tachykinin antagonists have potent local anaesthetic actions. Eur J Pharmacol 117:347–354
Radhakrishnan V, Henry JL (1991) Novel substance P antagonist, CP-96,345, blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neurosci Lett 132:39–43
Rouissi N, Gitter BD, Waters DC, Howbert JJ, Nixon JA, Regoli D (1991) Selectivity and specificity of new, non-peptide, quinuclidine antagonists of substance P. Biochem Biophys Res Commun 176:894–901
Snider RM, Constantine JW Lowe III JA, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW Hess H-J (1991) A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 251:435–437
von Euler US, Gaddum JH (1931) An unidentified depressor substance in certain tissue extracts. J Physiol (Lond) 72:74–87
Yachnis AT, Crawley JN, Jensen RT, McGrane MM, Moody TW (1984) The antagonism of bombesin in the CNS by substance P analogues. Life Sci 35:1963–1969